Short report. The AIDIT and IMPACT conference 2006: Outcomes and future directions

Collaborators, Affiliations

IMPACT steering committee and collaborators:
A Abele, M Altree, T Anagnostopoulos, A Ardern-Jones, B Arver, E Bancroft, C Bangma, G Bartsch, J Benitez, G Bevilacqua, I Blanco, O Bratt, C Brewer, R Bhohet, T Caldes, M Caligo, J Chang-Claude, C Chapman, G Chenevix-Trench, V Clowes, T Cole, J Cook, M Cook, C Cooper, L Copakova, D Cruger, C Cummings, R Davidson, D Dearneley, A Donaldson, H Dorkins, F Douglas, D Easton, D Eccles, R Eeles, G Evans, H Everaus, J Eyfjord, A Falconer, C Fisher, C Foster, E Friedman, C Furhauser, J Gardovskis, A M Gerdes, D Goldgar, H Gregory, H Grönberg, N Haites, F Hamdy, K Heimdal, S Hodgson, D Ilencikova, A Irmejs, L Izatt, O Jóhannsson, V Khoo, B Kiemeny, V Korn, Z Kote-Jarai, K Kyriacou, H Lilja, W Lilleby, G Lindeman, N Loman, J Lubinski, K Luedtke-Heckenkamp, G Luleci, L Lyubchenko, L Maehle, A Male, E Manguoglu, J Melia, G Mitchell, A Mitra, P Moller, C Moynihan, M Nansalmaa, N Nicolai, E Olah, H Olsson, A Osorio, P Osther, U Ozbek, J Papp, J Paterson, S Peock, M Peris, G Pichert, P Radice, T Rajkumar, G Rennert, M Rookus, A Salmon, R Schmutzler, F Schröder, P Segura, P Sibley, L Side, A Stapleton, M Stratton, M Suri, G Suthers, L Taylor, A Thompson, R Valdagni, C van Asperen, F van Leeuwen, H Vasen, T Wagner, P Wilson, D Yannoukakos, M A Young

¹ Translational Cancer Genetics Team, The Institute of Cancer Research, London, UK.

R Doherty et al. Hered Cancer Clin Pract. 2007.

. 2007 Mar 15;5(1):53-5.

doi: 10.1186/1897-4287-5-1-53.

IMPACT steering committee and collaborators:
A Abele, M Altree, T Anagnostopoulos, A Ardern-Jones, B Arver, E Bancroft, C Bangma, G Bartsch, J Benitez, G Bevilacqua, I Blanco, O Bratt, C Brewer, R Bhohet, T Caldes, M Caligo, J Chang-Claude, C Chapman, G Chenevix-Trench, V Clowes, T Cole, J Cook, M Cook, C Cooper, L Copakova, D Cruger, C Cummings, R Davidson, D Dearneley, A Donaldson, H Dorkins, F Douglas, D Easton, D Eccles, R Eeles, G Evans, H Everaus, J Eyfjord, A Falconer, C Fisher, C Foster, E Friedman, C Furhauser, J Gardovskis, A M Gerdes, D Goldgar, H Gregory, H Grönberg, N Haites, F Hamdy, K Heimdal, S Hodgson, D Ilencikova, A Irmejs, L Izatt, O Jóhannsson, V Khoo, B Kiemeny, V Korn, Z Kote-Jarai, K Kyriacou, H Lilja, W Lilleby, G Lindeman, N Loman, J Lubinski, K Luedtke-Heckenkamp, G Luleci, L Lyubchenko, L Maehle, A Male, E Manguoglu, J Melia, G Mitchell, A Mitra, P Moller, C Moynihan, M Nansalmaa, N Nicolai, E Olah, H Olsson, A Osorio, P Osther, U Ozbek, J Papp, J Paterson, S Peock, M Peris, G Pichert, P Radice, T Rajkumar, G Rennert, M Rookus, A Salmon, R Schmutzler, F Schröder, P Segura, P Sibley, L Side, A Stapleton, M Stratton, M Suri, G Suthers, L Taylor, A Thompson, R Valdagni, C van Asperen, F van Leeuwen, H Vasen, T Wagner, P Wilson, D Yannoukakos, M A Young

¹ Translational Cancer Genetics Team, The Institute of Cancer Research, London, UK.

No abstract available

References

1. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17:337–347. doi: 10.1002/pros.2990170409. - DOI - PubMed
1. Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ. 1992;305:855–857. doi: 10.1136/bmj.305.6858.855. - DOI - PMC - PubMed
1. Thompson D, Easton DF, Breast Cancer Linkage Consortium Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst. 2002;94:1358–1365. - PubMed
1. Thompson D, Easton D, Breast Cancer Linkage Consortium Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet. 2001;68:410–419. doi: 10.1086/318181. - DOI - PMC - PubMed
1. Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardern-Jones A, Murkin A, Dowe A, Kelly J, Williams S, Oram R, Stevens M, Teare DM, Ponder BA, Gayther SA, Easton DF, Eeles RA, Cancer Research UK/Bristish Prostate Group UK Familial Prostate Cancer Study Collaborators; British Association of Urological Surgeons Section of Oncology Two percent of men with early-onset prostate cancer harbour germline mutations in the BRCA2 gene. Am J Hum Genet. 2003;72:1–12. doi: 10.1086/345310. - DOI - PMC - PubMed